Buy PT-141 2026 — Bremelanotide for melanocortin receptor (MC3R/MC4R) research (EU)

Peptide Research · 28 June 2026 · 12 min read · Research Use Only

In short: PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide, structurally derived from the sequence of the melanocortin peptide α-MSH. This research guide summarises, the published in-vitro and animal model literature zu PT-141 documented – from melanocortin receptor binding to CNS models. At BlitzLab as 10mg vial with batch-related Certificate of Analysis (COA), HPLC ≥ 99 %, EU delivery. Price: 59.90. For research use only (RUO).

PT-141 at a glance

DesignationPT-141 (Bremelanotide)
IdentitySynthetic cyclic heptapeptide, structurally derived from α-MSH
SynonymsBremelanotide, PT141
Research contextMelanocortin receptor binding models (MC1R/MC3R/MC4R), CNS models (in-vitro/animal model)
CAS number189691-06-3 (the batch-specific COA is authoritative)
Molecular formulaC50H68N14O10
FormLyophilised powder (freeze-dried), sealed vial
Amount10 mg per vial
Purity≥99% (HPLC), identity confirmed by LC-MS
AnalysisExternal third-party laboratory, batch-specific COA
Intended useFor Research Use Only (RUO)
Price59.90 · Shipping from Germany

What is PT-141?

PT-141, with the international non-proprietary name Bremelanotide, is a synthetic Cyclic heptapeptide – a ring-closed peptide composed of seven amino acids. It is structurally derived from the sequence of the melanocortin peptide Alpha-MSH (alpha-melanocyte-stimulating hormone). Due to its cyclic architecture, PT-141 differs from linear peptides and is considered a well-characterised, defined reference substance from the melanocortin family in laboratory research. It is supplied as a stable lyophilised powder in a sealed vial (10 mg). CAS number (189691-06-3) and molecular formula (C50H68N14O10) are documented in the batch-related certificate of analysis.

Molecular profile & target structure

As a heptapeptide, PT-141 consists of seven amino acid building blocks, which are closed into a ring; the molecular formula C50H68N14O10 reflects this compact, nitrogen-rich structure. The structural similarity to Alpha-MSH places the substance into the context of the melanocortin system: In the literature, PT-141 is investigated as a ligand that binds to members of the Melanocortin receptor family binds – including MC1R, MC3R and MC4R. These receptors belong to the G-protein-coupled receptors. The combination of a defined, cyclic sequence and its relationship to a natural melanocortin peptide makes PT-141 a frequently used reference in receptor and neurobiological study models.

What in-vitro and animal model studies document

The following summary reflects only what is described in the publicly accessible preclinical literature – it is not a statement about an effect or suitability in humans.

These observations originate from in-vitro and animal models. They justify the research interest in PT-141, but do not make any statements regarding safety, efficacy, or any application outside of laboratory research.

Purity, COA & Analytical Testing

Purity and identity are the two values that count. HPLC demonstrates purity (target value ≥ 99 %), LC-MS confirms the identity via the molecular mass – for a cyclic heptapeptide like PT-141, the correct mass is an important proof of identity. Both values are stated in the batch-related COA. We explain how to read such a certificate in Understanding and reading a Certificate of Analysis (COA); the procedures themselves in Peptide Purity: HPLC and LC-MS Explained.

Storage & Handling

As a lyophilised product, PT-141 is stable when it is kept cool, dry and protected from light and stored – ideally at -20°C for longer storage. Please refer to the COA for batch-specific information. Principles: Storing and Handling Research Peptides.

Buying PT-141 in the EU – what matters

What matters is not the price, but this: Does the label match the contents? Here's what BlitzLab delivers on:

What else to look out for with a reputable provider: 7-point checklist.

Frequently asked questions about buying PT-141

No. PT-141 is strictly for scientific in-vitro laboratory research (Research Use Only) – not for human or animal use.
Published in-vitro and animal model studies have investigated PT-141 (bremelanotide), among other things, in binding models on melanocortin receptors (MC1R/MC3R/MC4R) and in CNS models. This summarises research observations and is not a statement about human application.
Yes. Each batch is tested externally by HPLC and LC-MS; the batch-specific COA is available on the Product page inspectable.
Yes. Shipped in plain packaging from Germany; within the EU delivery usually takes 2–5 working days, with tracking.

Note on Sources & RUO

This guide summarises publicly available preclinical research literature (in vitro and animal models) on PT-141. The accompanying Certificate of Analysis is always authoritative for the identity, CAS number, molecular formula and purity of the supplied batch. All information is for informational purposes within a research context (Research Use Only) and does not constitute medical advice, dosage, or application recommendations.

PT-141 10 mg – View batch with COA

Certificate of Analysis, specification, and availability directly on the product page.

To the product